XNCR Xencor Inc

Price (delayed)

$41.78

Market cap

$2.42B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.21

Enterprise value

$2.27B

Sector: Healthcare
Industry: Biotechnology

Highlights

The company's net income rose by 16% QoQ
The EPS has increased by 16% QoQ
The gross profit has increased by 45% from the previous quarter but it has decreased by 22% YoY
XNCR's revenue is up by 45% since the previous quarter but it is down by 22% year-on-year
XNCR's quick ratio is down by 39% year-on-year and by 36% since the previous quarter
Xencor's debt has increased by 22% QoQ and by 8% YoY

Key stats

What are the main financial stats of XNCR
Market
Shares outstanding
57.95M
Market cap
$2.42B
Enterprise value
$2.27B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.19
Price to sales (P/S)
19.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.49
Earnings
Revenue
$122.69M
EBIT
-$69.33M
EBITDA
-$63.54M
Free cash flow
-$15.54M
Per share
EPS
-$1.21
Free cash flow per share
-$0.27
Book value per share
$9.96
Revenue per share
$2.14
TBVPS
$12.01
Balance sheet
Total assets
$703.24M
Total liabilities
$130.8M
Debt
$11.63M
Equity
$572.44M
Working capital
$516.61M
Liquidity
Debt to equity
0.02
Current ratio
5.27
Quick ratio
5.08
Net debt/EBITDA
2.39
Margins
EBITDA margin
-51.8%
Gross margin
100%
Net margin
-56.5%
Operating margin
-62.6%
Efficiency
Return on assets
-10.4%
Return on equity
-12%
Return on invested capital
-14.5%
Return on capital employed
-11.9%
Return on sales
-56.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XNCR stock price

How has the Xencor stock price performed over time
Intraday
-1.14%
1 week
5.53%
1 month
-9.61%
1 year
42.11%
YTD
-4.24%
QTD
-2.97%

Financial performance

How have Xencor's revenue and profit performed over time
Revenue
$122.69M
Gross profit
$122.69M
Operating income
-$76.8M
Net income
-$69.33M
Gross margin
100%
Net margin
-56.5%
The gross profit has increased by 45% from the previous quarter but it has decreased by 22% YoY
XNCR's revenue is up by 45% since the previous quarter but it is down by 22% year-on-year
XNCR's operating margin is up by 44% since the previous quarter
Xencor's net margin has increased by 42% QoQ

Growth

What is Xencor's growth rate over time

Valuation

What is Xencor stock price valuation
P/E
N/A
P/B
4.19
P/S
19.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.49
The EPS has increased by 16% QoQ
XNCR's P/B is 18% above its 5-year quarterly average of 3.6 and 18% above its last 4 quarters average of 3.6
XNCR's equity is down by 3.5% year-on-year
XNCR's revenue is up by 45% since the previous quarter but it is down by 22% year-on-year
XNCR's P/S is 17% below its last 4 quarters average of 23.7 and 14% below its 5-year quarterly average of 22.9

Efficiency

How efficient is Xencor business performance
The ROS has increased by 42% QoQ
The ROA has grown by 17% from the previous quarter
XNCR's ROE is up by 15% from the previous quarter
The ROIC has grown by 10% from the previous quarter

Dividends

What is XNCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XNCR.

Financial health

How did Xencor financials performed over time
XNCR's total liabilities has surged by 70% year-on-year and by 68% since the previous quarter
XNCR's quick ratio is down by 39% year-on-year and by 36% since the previous quarter
Xencor's debt is 98% lower than its equity
Xencor's debt has increased by 22% QoQ and by 8% YoY
XNCR's equity is down by 3.5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.